Applied Industrial Technologies, Inc. — FY2020 Form 10-K
Reporting period: Fiscal year ended June 30, 2020. The request metadata says “2019 Q4,” but the supplied filing is the FY2020 10-K; its fourth-quarter figures are for the three months ended June 30, 2020.
Business context
Applied distributes and provides technical solutions for industrial motion, fluid power, flow control, and automation products, serving MRO and OEM customers. It reported two segments: Service Center Based Distribution (69% of FY2020 sales) and Fluid Power & Flow Control (31%). The company acquired automation solutions provider Olympus Controls in August 2019.
Financial performance and liquidity
| Metric | FY2020 | FY2019 |
|---|---|---|
| Net sales | $3.246 billion | $3.473 billion |
| Gross margin | 28.9% | 29.0% |
| Operating income / margin | $89.0 million / 2.7% | $233.8 million / 6.7% |
| Net income | $24.0 million | $144.0 million |
| Diluted EPS | $0.62 | $3.68 |
| Cash from operations | $296.7 million | $180.6 million |
- Sales declined 6.5%; excluding acquisitions and currency, sales fell 8.5%. Organic declines reflected weak end-market demand and the COVID-19 slowdown.
- Service Center Based Distribution sales fell 8.6% to $2.242 billion; Fluid Power & Flow Control sales fell 1.6% to $1.004 billion. Acquisitions added $80.7 million to consolidated sales.
- A $131.0 million non-cash goodwill impairment tied to FCX materially reduced reported operating income and net income. The impairment reduced FY2020 net income by $118.8 million and diluted EPS by $3.04. FY2019 included a $31.6 million intangible-asset impairment in Canadian operations.
- Cash from operations increased, supported in part by reductions in receivables and inventory. Capital expenditures were $20.1 million; dividends paid were $48.9 million, or $1.26 per share.
- At June 30, 2020, cash and cash equivalents were $268.6 million, total debt was $935.3 million, working capital was $733.7 million, and the current ratio was 2.7. Available revolving-credit capacity was about $248.1 million; the company reported compliance with debt covenants.
- Receivables quality weakened: provision for doubtful accounts rose to $14.1 million from $4.1 million, and receivables more than 90 days past due increased to 4.6% from 3.0%.
Material changes and unusual items
- COVID-19 reduced customer production and demand, particularly in the second half. Facilities remained open as critical infrastructure. Management reported organic sales down mid-teens year over year through early August 2020.
- FY2020 included $9.0 million of non-routine costs for location consolidation and headcount reductions, including $3.9 million in inventory reserves and $5.1 million in severance and facility-consolidation costs.
- The effective tax rate was 56.5%, primarily because the FCX goodwill impairment increased the rate; the CARES Act provided a $1.0 million tax benefit.
- Cash increased to $268.6 million from $108.2 million. Debt repayments, lower working-capital balances, and the Olympus acquisition affected cash flows and financing activity.
- The company adopted the new lease standard, recognizing $83.5 million of right-of-use assets and $89.8 million of lease liabilities at adoption. Auditors issued unqualified opinions on the financial statements and internal controls.
Outlook, commentary, and risks
- Management did not provide full-year FY2021 sales or earnings guidance in the supplied text. It described underlying demand as subdued but stabilizing and continued cost-control actions, including reduced discretionary spending, furloughs, pay reductions, and suspension of the 401(k) match.
- FY2021 planned capital expenditures were $15–$20 million; expected depreciation was $22.5–$23.5 million. Management expected an income tax rate of 23%–25% and inventory turnover slightly better than FY2020.
- FCX goodwill remaining after impairment was $309.0 million, and the reporting unit’s fair value approximated carrying value after the charge; further weakness or failure to achieve forecasts could trigger additional impairment.
- Other significant risks include prolonged COVID-19 disruption, industrial cyclicality, customer credit deterioration, supplier availability and incentives, pricing and margin pressure, acquisition integration, leverage and variable interest rates, foreign exchange exposure, and information-system or cybersecurity disruption.
- Pending legal proceedings were not expected by management to have a material adverse effect based on circumstances then known. The filing cautions that outcomes and forward-looking statements remain uncertain.
Most important facts for investors to verify
- Whether demand recovered from the mid-teens organic sales decline reported through early August 2020, and how performance varied by segment and end market.
- FCX’s operating performance and valuation assumptions, including the risk of further goodwill impairment.
- Receivables aging, bad-debt provisions, and cash generation as customer credit conditions evolve.
- Debt maturities, covenant headroom, interest-rate exposure, and availability under the receivables securitization facility.
- Whether management’s FY2021 cost, capital-expenditure, tax-rate, and inventory-turnover expectations were achieved.